Trading Day Triumph: Celestica, Inc (CLS) Ends at $303.22, a -0.11 Surge/Plunge

Nora Barnes

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

Celestica, Inc (NYSE: CLS) closed the day trading at $303.22 down -0.11% from the previous closing price of $303.56. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 1.33 million shares were traded. CLS stock price reached its highest trading level at $308.53 during the session, while it also had its lowest trading level at $293.08.

Ratios:

For a better understanding of CLS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 114.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 87.77. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 1.47. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.43.

On October 16, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $340.

TD Securities Downgraded its Buy to Hold on October 03, 2025, while the target price for the stock was maintained at $238.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 01 ’25 when Wong Leila sold 3,160 shares for $323.38 per share. The transaction valued at 1,021,881 led to the insider holds 13,892 shares of the business.

Etienvre Yann L sold 9,187 shares of CLS for $2,970,892 on Dec 01 ’25. The Chief Operations Officer now owns 0 shares after completing the transaction at $323.38 per share. On Dec 01 ’25, another insider, Wong Leila, who serves as the Officer of the company, bought 3,160 shares for $344.41 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLS now has a Market Capitalization of 34881404928 and an Enterprise Value of 35361103872. As of this moment, Celestica,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 49.21, and their Forward P/E ratio for the next fiscal year is 35.90. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.83. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.09 while its Price-to-Book (P/B) ratio in mrq is 17.19. Its current Enterprise Value per Revenue stands at 3.134 whereas that against EBITDA is 31.76.

Stock Price History:

The Beta on a monthly basis for CLS is 1.85, which has changed by 2.2888408 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, CLS has reached a high of $363.40, while it has fallen to a 52-week low of $58.05. The 50-Day Moving Average of the stock is -3.23%, while the 200-Day Moving Average is calculated to be 54.42%.

Shares Statistics:

Over the past 3-months, CLS traded about 2.95M shares per day on average, while over the past 10 days, CLS traded about 2717410 shares per day. A total of 115.00M shares are outstanding, with a floating share count of 114.35M. Insiders hold about 0.60% of the company’s shares, while institutions hold 73.74% stake in the company. Shares short for CLS as of 1765756800 were 3481694 with a Short Ratio of 1.18, compared to 1763078400 on 3389445. Therefore, it implies a Short% of Shares Outstanding of 3481694 and a Short% of Float of 3.04.

Earnings Estimates

The stock of Celestica, Inc (CLS) is currently in the spotlight, with 16.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $1.83, with high estimates of $2.02 and low estimates of $1.69.

Analysts are recommending an EPS of between $6.02 and $5.84 for the fiscal current year, implying an average EPS of $5.93. EPS for the following year is $8.41, with 16.0 analysts recommending between $9.27 and $8.19.

Revenue Estimates

14 analysts predict $3.49B in revenue for. The current quarter. It ranges from a high estimate of $3.62B to a low estimate of $3.35B. As of. The current estimate, Celestica, Inc’s year-ago sales were $2.55BFor the next quarter, 14 analysts are estimating revenue of $3.6B. There is a high estimate of $3.84B for the next quarter, whereas the lowest estimate is $3.49B.

A total of 16 analysts have provided revenue estimates for CLS’s current fiscal year. The highest revenue estimate was $12.35B, while the lowest revenue estimate was $12.09B, resulting in an average revenue estimate of $12.22B. In the same quarter a year ago, actual revenue was $9.65BBased on 16 analysts’ estimates, the company’s revenue will be $16.3B in the next fiscal year. The high estimate is $17.13B and the low estimate is $15.96B.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.